We are live on ! Find out more
BC

Birchview Capital Portfolio holdings

AUM $176M
1-Year Est. Return 95.04%
This Fund
S&P 500
This Quarter Est. Return
-7.77%
1 Year Est. Return
+95.04%
3 Year Est. Return
+233.14%
5 Year Est. Return
+280.2%
10 Year Est. Return
+1,023.63%
AUM
$150M
AUM Growth
-$15.8M
Cap. Flow
+$2.4M
Cap. Flow %
1.6%
Top 10 Hldgs %
78.1%
Holding
51
New
–
Increased
6
Reduced
3
Closed
1

Top Buys

Rank Stock Value
1
QDEL icon
QuidelOrtho
QDEL
+$1.72M
2
BMY.RT
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
+$1.43M
3
ACAD icon
Acadia Pharmaceuticals
ACAD
+$389K
4
ALBO
Albireo Pharma Inc
ALBO
+$291K
5
AMRN
Amarin Corp
AMRN
+$240K

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$769K
2
AWH
Aspira Women's Health Inc. Common Stock
AWH
+$709K
3
NARI
Inari Medical, Inc. Common Stock
NARI
+$193K
4
WKHS icon
Workhorse Group
WKHS
+$114K

Sector Composition

Rank Sector Weight
1 Healthcare 95.26%
2 Energy 1.16%
3 Consumer Discretionary 0.13%
4 Consumer Staples 0.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GILD icon
51
Gilead Sciences
GILD
$161B
– –
-10,000
Closed -$769K
1 2
3

Similar funds

RWA
Resolute Wealth Advisor Findlay, Ohio $176M AUM
BAM
Boyar Asset Management New York $176M AUM 20.04% 1-Year Est. Return
TIM
Tevis Investment Management Plano, Texas $176M AUM 18.14% 1-Year Est. Return
LWM
Lifetime Wealth Management Rockwall, Texas $176M AUM
PFA
Providence Financial Advisors Overland Park, Kansas $175M AUM
DAM
Draper Asset Management Smithtown, New York $176M AUM 37.45% 1-Year Est. Return
AF
Align Financial Hermantown, Minnesota $176M AUM
OA
Oceanside Advisors Mount Pleasant, South Carolina $175M AUM 17.96% 1-Year Est. Return

Birchview Capital's Q3 2020 Portfolio in Review

As of Q3 2020, Birchview Capital held 51 positions worth $150M, down 9.5% from $165M the previous quarter. Its ten largest holdings account for 78% of the portfolio.

Trading was light in Q3 2020: portfolio turnover was 2%. Birchview Capital opened no new positions and exited 1, leaving the 51-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 95% of assets, down from 96% a quarter earlier, followed by Energy and Consumer Discretionary.

  • Birchview Capital added most to QuidelOrtho in Q3 2020, an estimated $1.72M increase.
  • Birchview Capital's biggest Q3 2020 reduction was Aspira Women's Health Inc. Common Stock, cutting an estimated $709K.
  • Birchview Capital fully exited Gilead Sciences in Q3 2020, selling an estimated $769K.
  • Birchview Capital's ten largest holdings make up 78% of its $150M portfolio in Q3 2020.
  • Birchview Capital opened 0 new positions and closed 1 in Q3 2020.
  • Birchview Capital's portfolio value fell 9.5% quarter-over-quarter to $150M.

Based on Birchview Capital's 13F filing for Q3 2020, filed 12 Nov 2020.